Press release
Global Medical Asparaginase Sales Market Industry Trend and Forecast 2025
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification of Medical Asparaginase includes Escherichia coli, Erwinia Chrysanthemi and Pegylated, and the sales proportion of Escherichia coli in 2017 is about 64.6%, and the proportion is decreasing trend from 2013 to 2018.
Medical Asparaginase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Medical Asparaginase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 90% in 2017.
North America is the largest consumption place, with a revenue market share nearly 53.5% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 37.2%, China is also an important sales region for the Medical Asparaginase, In China, the price is lower than the developed countries.
Market competition is intense. Jazz Pharmaceuticals, Shire, Medac GmbH, Kyowa Hakko Kirin, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
The global Medical Asparaginase market is valued at 390 million US$ in 2017 and will reach 440 million US$ by the end of 2025, growing at a CAGR of 1.4% during 2018-2025.
The major players covered in this report
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Escherichia coli
Erwinia Chrysanthemi
Pegylated
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
The study objectives of this report are:
To analyze and study the global Medical Asparaginase sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Medical Asparaginase players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Medical Asparaginase are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/176a06942accc088edaacb7353438e3b,0,1
Key Stakeholders
Medical Asparaginase Manufacturers
Medical Asparaginase Distributors/Traders/Wholesalers
Medical Asparaginase Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Medical Asparaginase market, by end-use.
Detailed analysis and profiles of additional market players.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/265838/global-medical-asparaginase-sales-market
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – enquiry@qyrsearch.com
Web – www.qyresearch.com
Expert News: www.qyresearch.com/expert/list
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Medical Asparaginase Sales Market Industry Trend and Forecast 2025 here
News-ID: 1173239 • Views: …
More Releases for Asparaginase
Asparaginase Market Future Prediction Report By 2028
Asparaginase Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Download…
Asparaginase Market Significantly Stepping towards the Success Till 2027|
Asparaginase is an enzyme that is used in both medicine and food production. L-asparaginase is a medication used to treat acute lymphoblastic leukemia (ALL). It is administered via injection into a vein, muscle, or beneath the skin. In 2020, the global Asparaginase market size was US$ 359 million and it is expected to reach US$ 399.2 million by the end of 2027, with a CAGR of 1.5% during 2021-2027.
Request Sample…
Asparaginase Market to Witness Robust Expansion by 2024
Market Research Report Store offers a latest published report on Asparaginase Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Asparaginase market will register a 1.2% CAGR in terms of revenue, the global market size will reach US$ 396.8 million by 2024, from US$ 378.6 million in 2019. In particular, this…
L-Asparaginase Market Size, Share, Development by 2024
Global Info Research offers a latest published report on L-Asparaginase Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-l-asparaginase-market_p130165.html
Scope of the Report:
The worldwide market for L-Asparaginase is…
Global Asparaginase Market
The “Global Asparaginase Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Asparaginase Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product…
Global Asparaginase Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Asparaginase in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Asparaginase market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Kyowa Hakko Kirin
Alize Pharma
Jinan Welcome Biochemical Pharmaceutical
Guangzhou Baiyuan Shanmingxing Pharmaceutical
United Biotech
GIHI Chemicals
Changzhou Qianhong Bio-pharma
Liaoyuan Dikang
ZHPHARMA
Taj Pharmaceuticals
Porton Biopharma
On…
